Untitled Document
www.expresspharmaonline.com FORTNIGHTLY INSIGHT FOR PHARMA PROFESSIONALS
16-31 August 2008  
Untitled Document
Sections

Market
Management
South Pharma Spl.
Research
Pharma Life
Express Biotech

Services
Open Forum
Appointments
Subscribe/Renew
Archives
Editorial Calendar
Media Kit
Contact Us
Network Sites
Express Computer
CIO Decisions
Express Channel Business
Express Hospitality
Express TravelWorld
feBusiness Traveller
Express Healthcare
Express Textile
Group Sites
ExpressIndia
Indian Express
Financial Express




     EXPRESS BIOTECH
 

Opinion

The age of IP
From its initial years, the biotechnology industry was projected as the 'David' to Big Pharma's 'Goliath'. And true to the story, the smaller industry is today proving that agility and brain will win over mere size

Market

The cure within
The life saving nature of blood was always known, but it's therapeutic nature had seldom been explored, until plasma fractionation. Suja Nair surveys the scenario

Venkateshwara Hatcheries to start human biopharma activity
The Pune- based Venkateshwara Hatcheries (VH) will start a fully integrated human biopharmacetuical manufacturing activity by setting up a new venture, Uttara Biosciences (Uttara)

Jubilant enters into drug discovery pact with Amgen
Jubilant Biosys, a wholly owned subsidiary of Jubilant Organosys has recently entered into a drug discovery agreement with US based biotech company Amgen

India launch of breast cancer drug Abraxane
Biocon has joined hands with Abraxis BioScience for the launch of Abraxane (paclitaxel albumin-bound particles for injectable suspension) in India

Hand in hand
A recent report shows a slowdown in the growth rate of the Indian biotechnology industry in the last fiscal. This is however only a temporary dip before the next growth spurt

Management

'Tech'ing forward
Scientific instrumentation and engineering has been the silent force behind the many milestones in the biotechnology industry. Sachin Jagdale reveals more

Gene expression
Gene expression in the simplest terms can be defined as a process, by which inheritable information from a gene, such as the DNA sequence, is made or expressed into a functional gene product

Indian companies can 'leapfrog' to be on the cutting edge
John M Hyde, CEO, Chairman and Founder, and Karan Manocha, Senior Pharmaceutical Engineer, J M Hyde Consulting discuss with Viveka Roychowdhury why the Indian biotechology industry is at an exciting juncture today

Technology

Reality check on oral insulin
Though Big Pharma seems to have given up on oral insulin, a few biotechnology companies continue research in this direction. Express Pharma reviews the research


Untitled Document
Untitled Document
© Copyright 2001: Indian Express Newspapers (Mumbai) Limited (Mumbai, India). All rights reserved throughout the world. This entire site is compiled in Mumbai by the Business Publications Division (BPD) of the Indian Express Newspapers (Mumbai) Limited. Site managed by BPD.